TY - JOUR
T1 - Lockdown of Breast Cancer Screening for COVID-19
T2 - Possible Scenario
AU - Vanni, Gianluca
AU - Pellicciaro, Marco
AU - Materazzo, Marco
AU - Bruno, Valentina
AU - Oldani, Chiara
AU - Pistolese, Chiara Adriana
AU - Buonomo, Chiara
AU - Caspi, Jonathan
AU - Gualtieri, Paola
AU - Chiaravalloti, Agostino
AU - Palombi, Leonardo
AU - Piccione, Emilio
AU - Buonomo, Oreste Claudio
N1 - Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
PY - 2020/9/3
Y1 - 2020/9/3
N2 - BACKGROUND/AIM: Coronavirus disease is spreading worldwide. Due to fast transmission and high fatality rate drastic emergency restrictions were issued. During the lockdown, only urgent medical services are guaranteed. All non-urgent services, as breast cancer (BC) screening, are temporarily suspended. The potential of breast cancer screening programs in increasing the survival rate and decreasing the mortality rate has been widely confirmed. Suspension could lead to worse outcomes for breast cancer patients. Our study aimed to analyse the data and provide estimates regarding the temporary BC screening suspension.PATIENTS AND METHODS: Data regarding breast cancer and respective screening programs were achieved through literature research and analysis.RESULTS: Considering three different scenarios with respect to the lockdown's impact on breast cancer screening, we estimate that approximately 10,000 patients could have a missed diagnosis during these 3 months. Considering a 6-month period, as suggested by the Imperial college model, the number of patients who will not receive a diagnosis will rise to 16,000.CONCLUSION: Breast cancer screening should be resumed as soon as possible in order to avoid further breast cancer missed diagnosis and reduce the impact of delayed diagnosis.
AB - BACKGROUND/AIM: Coronavirus disease is spreading worldwide. Due to fast transmission and high fatality rate drastic emergency restrictions were issued. During the lockdown, only urgent medical services are guaranteed. All non-urgent services, as breast cancer (BC) screening, are temporarily suspended. The potential of breast cancer screening programs in increasing the survival rate and decreasing the mortality rate has been widely confirmed. Suspension could lead to worse outcomes for breast cancer patients. Our study aimed to analyse the data and provide estimates regarding the temporary BC screening suspension.PATIENTS AND METHODS: Data regarding breast cancer and respective screening programs were achieved through literature research and analysis.RESULTS: Considering three different scenarios with respect to the lockdown's impact on breast cancer screening, we estimate that approximately 10,000 patients could have a missed diagnosis during these 3 months. Considering a 6-month period, as suggested by the Imperial college model, the number of patients who will not receive a diagnosis will rise to 16,000.CONCLUSION: Breast cancer screening should be resumed as soon as possible in order to avoid further breast cancer missed diagnosis and reduce the impact of delayed diagnosis.
KW - Aged
KW - Betacoronavirus/pathogenicity
KW - Breast Neoplasms/complications
KW - Coronavirus Infections/complications
KW - Early Detection of Cancer
KW - Female
KW - Humans
KW - Mammography
KW - Mass Screening/trends
KW - Middle Aged
KW - Pandemics
KW - Pneumonia, Viral/complications
U2 - 10.21873/invivo.12139
DO - 10.21873/invivo.12139
M3 - Article
C2 - 32871851
VL - 34
SP - 3047
EP - 3053
JO - In Vivo
JF - In Vivo
SN - 0258-851X
IS - 5
ER -